Biotech, VC, deals
Vaccsys Raises $9M in Series A
Gregory T. Huang 6/19/08
Vaccsys, a vaccine maker based in Seattle, has called down $9 million of an $18 million Series A round, according to Private Equity Hub, which cites a regulatory filing. The investors include Alta Partners, The Column Group, and Versant Ventures (all based in California).
Gregory T. Huang is the Editor of Xconomy Seattle. You can e-mail him at gthuang@xconomy.com or call 206-624-2249.
